Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

NCT01792960 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2014-02-19

No results posted yet for this study

Summary

Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy

Conditions

  • Familial Hypertrophic Cardiomyopathy

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01792960 on ClinicalTrials.gov